Pouring generic approval of ‘Dexid Tab’ generics, will enlarge market of diabetic neuropathy therapies?

Dexid Tab, a diabetic neuropathy therapy, were reportedly referenced by more than 40 generic drugs to acquire approval.

The market size of Dexid Tab is calculated at approximately KRW 10 billion, but it seems it will get enlarged since it is a treatment which can generate new patients if competition among these generics is fueled.

According to the Ministry of Food and Drug Safety(MFDS), the P...